By Ekaterina Pesheva – Harvard Medical School –
New AI tool accurately identifies multiple drivers of disease in cells and predicts therapies that can restore cells to healthy function.
In a move that could reshape drug discovery, researchers at Harvard Medical School have designed an artificial intelligence model capable of identifying treatments that reverse disease states in cells.
Unlike traditional approaches that typically test one protein target or drug at a time in hopes of identifying an effective treatment, the new model, called PDGrapher and available for free, focuses on multiple drivers of disease and identifies the genes most likely to revert diseased cells back to healthy function.
